| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $179.0M | +5.1% |
| Cost of Revenue | $72.1M | -4.6% |
| R&D Expense | $103.0M | -15.7% |
| SG&A Expense | $72.8M | -13.3% |
| Operating Income | -$162.5M | +28.4% |
| Interest Expense | $11.6M | -16.1% |
| Pre-tax Income | -$159.6M | +29.2% |
| Net Income | -$159.5M | +29.2% |
| EPS (Basic) | -$1.08 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $47.9M | -26.3% |
| Accounts Receivable | $41.7M | +9.9% |
| Inventory | $8.4M | -41.6% |
| Current Assets | $283.8M | -30.8% |
| Total Assets | $539.4M | -18.4% |
| Current Liabilities | $98.1M | +11.4% |
| Long-term Debt | $132.4M | +1.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$95.2M | +39.1% |
| Capital Expenditures | $3.7M | -65.7% |
| Investing Cash Flow | $77.8M | -40.0% |
| Financing Cash Flow | $241K | -89.3% |
| Free Cash Flow | -$98.9M | +40.8% |
| +30.8% |
| EPS (Diluted) | -$1.08 | +30.8% |
| Total Liabilities |
| $336.9M |
| -4.5% |
| Stockholders' Equity | $202.7M | -34.3% |